Latest Av Therapeutics Inc (AVTH) Headlines A
Post# of 4
Posted On: 03/08/2014 11:54:55 PM
Latest Av Therapeutics Inc (AVTH) Headlines
AV Therapeutics Announces Collaboration With DavosPharma to Manufacture Chemotherapeutic Drug Capridine
GlobeNewswire - Wed Feb 05, 6:00AM CST
AV Therapeutics, Inc., ("AV Therapeutics" or "the Company") (OTCQB:AVTH), a developer of cancer therapeutics and vaccines, today announced that it has entered into an agreement with DavosPharma, a New Jersey-based company with 40 years of experience manufacturing drugs for the biotech industry, to assist in the Good Manufacturing Practices (GMP) synthesis of its lead drug candidate Capridine.
AV Therapeutics Announces Information Available Through S&P's Corporation Records Program
GlobeNewswire - Wed Jan 22, 10:28AM CST
AV Therapeutics, Inc. ("AV Therapeutics" or the "Company") (OTCQB:AVTH), a developer of cancer therapeutics and vaccines, announced that its company information is now available via Standard & Poor's Corporation Records Listing Program. As part of the program, a full description of AV Therapeutics was published in the Daily News Section of Standard & Poor's Corporation Records, a recognized securities manual for secondary trading in up to 38 States under the Blue Sky Laws. Standard & Poor's Corporation Records is available in print, CD-ROM, and via the web at www.netadvantage.standardandpoors.com as well as through numerous electronic vendors.
AV Therapeutics Begins Trading on the OTCQB Under the Symbol "AVTH"
GlobeNewswire - Thu Jan 02, 6:00AM CST
AV Therapeutics, Inc. ("AV Therapeutics" or the "Company") (OTCQB:AVTH), a developer of cancer therapeutics and vaccines, announced that its common stock began trading on the OTC Market Group's OTCQB Marketplace ("OTCQB") under the symbol "AVTH" on December 27, 2013.
AV Therapeutics Announces Collaboration With DavosPharma to Manufacture Chemotherapeutic Drug Capridine
GlobeNewswire - Wed Feb 05, 6:00AM CST
AV Therapeutics, Inc., ("AV Therapeutics" or "the Company") (OTCQB:AVTH), a developer of cancer therapeutics and vaccines, today announced that it has entered into an agreement with DavosPharma, a New Jersey-based company with 40 years of experience manufacturing drugs for the biotech industry, to assist in the Good Manufacturing Practices (GMP) synthesis of its lead drug candidate Capridine.
AV Therapeutics Announces Information Available Through S&P's Corporation Records Program
GlobeNewswire - Wed Jan 22, 10:28AM CST
AV Therapeutics, Inc. ("AV Therapeutics" or the "Company") (OTCQB:AVTH), a developer of cancer therapeutics and vaccines, announced that its company information is now available via Standard & Poor's Corporation Records Listing Program. As part of the program, a full description of AV Therapeutics was published in the Daily News Section of Standard & Poor's Corporation Records, a recognized securities manual for secondary trading in up to 38 States under the Blue Sky Laws. Standard & Poor's Corporation Records is available in print, CD-ROM, and via the web at www.netadvantage.standardandpoors.com as well as through numerous electronic vendors.
AV Therapeutics Begins Trading on the OTCQB Under the Symbol "AVTH"
GlobeNewswire - Thu Jan 02, 6:00AM CST
AV Therapeutics, Inc. ("AV Therapeutics" or the "Company") (OTCQB:AVTH), a developer of cancer therapeutics and vaccines, announced that its common stock began trading on the OTC Market Group's OTCQB Marketplace ("OTCQB") under the symbol "AVTH" on December 27, 2013.
(0)
(0)AV Therapeutics Inc. (AVTH) Stock Research Links
Scroll down for more posts ▼